trypsin drug
Evidence from:
primary |
all sources
No related entities found.
Mentioned in (14)
Papers in which this entity is mentioned.
- LINE-1 retrotransposons mediate cis-acting transcriptional control in human pluripotent stem cells and regulate early brain development. (2025)
- Single-molecule methylation profiles of cell-free DNA in cancer with nanopore sequencing. (2023)
- Most non-canonical proteins uniquely populate the proteome or immunopeptidome. (2021)
- Mutational processes shape the landscape of TP53 mutations in human cancer. (2018)
- Positively selected enhancer elements endow osteosarcoma cells with metastatic competence. (2018)
- Orthotopic patient-derived xenografts of paediatric solid tumours. (2017)
- Interaction of glycosphingolipids GD3 and GD2 with growth factor receptors maintains breast cancer stem cell phenotype. (2017)
- Extrachromosomal oncogene amplification drives tumour evolution and genetic heterogeneity. (2017)
- Medulloblastoma-associated DDX3 variant selectively alters the translational response to stress. (2016)
- The cell cycle regulator CCDC6 is a key target of RNA-binding protein EWS. (2015)
- A Sleeping Beauty forward genetic screen identifies new genes and pathways driving osteosarcoma development and metastasis. (2015)
- Effects of ethanol and NAP on cerebellar expression of the neural cell adhesion molecule L1. (2011)
- An RNA code for the FOX2 splicing regulator revealed by mapping RNA-protein interactions in stem cells. (2009)
- An alcohol binding site on the neural cell adhesion molecule L1. (2008)
Merged raw entities (4)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| trypsin | drug | 55 | 75 |
| 0.05% trypsin | drug | — | — |
| 0.25% trypsin | drug | — | — |
| bovine pancreatic trypsin | drug | — | — |